Ortho-McNeil, Inc.
6
0
0
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 70/100
66.7%
4 terminated/withdrawn out of 6 trials
33.3%
-53.2% vs industry average
33%
2 trials in Phase 3/4
50%
1 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Pain Study to See if Ultram ER Will Provide Relief to Subjects Whose Pain is Not Well Controlled by Narcotics
Role: collaborator
Topiramate in the Treatment of Pathological Gambling
Role: collaborator
Post-nasal Drainage as an Extraesophageal Manifestation of Reflux
Role: collaborator
The Utility of Levofloxacin-Rifampin in the Therapy of Prosthetic Joint Infection
Role: collaborator
Paliperidone Palmitate Efficacy and Safety in Bipolar Disorder Complicated by Alcoholism
Role: collaborator
Continuous Use of the Contraceptive Patch and the Personal Economic Impact.
Role: collaborator
All 6 trials loaded